Prague Med. Rep. 2017, 118, 95-99
https://doi.org/10.14712/23362936.2017.9
IgG4-related Disease – A Patient with Multiple Organ Involvement
References
1. , P., Ramos-Casals, M., Bosch, X., Stone, J. H. (2014) The clinical spectrum of IgG4-related disease. Autoimmun. Rev. 13, 1203–1210.
<https://doi.org/10.1016/j.autrev.2014.08.013>
2. , M., Grados, A., Bernit, E., Vely, F., Boucraut, J., Harle, J. R., Daniel, L., Schleinitz, N. (2012) Pathologies associated with serum IgG4 elevation. Int. J. Rheumatol. 2012, 602809.
<https://doi.org/10.1155/2012/602809>
<PubMed>
3. , T., Zen, Y., Pillai, S., Stone, J. H. (2015) IgG4-related disease. Lancet 385, 1460–1471.
<https://doi.org/10.1016/S0140-6736(14)60720-0>
4. , V. S., Mattoo, H., Deshpande, V., Pillai, S. S., Stone, J. H. (2014) IgG4-related disease. Annu. Rev. Pathol. 9, 315–347.
<https://doi.org/10.1146/annurev-pathol-012513-104708>
5. , M., Kolombo, I., Štádler, P. (2016) Combination of steroids and azathioprine in the treatment of Ormond’s disease – A single centre retrospective analysis. Prague Med. Rep. 117(1), 34–41.
<https://doi.org/10.14712/23362936.2016.3>
6. , J. H., Brito-Zerón, P., Bosch, X., Ramos-Casals, M. (2015) Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin. Proc. 90, 927–939.
<https://doi.org/10.1016/j.mayocp.2015.03.020>
7. , E. F. H., Siemes, C., Hak, L. E., van der Veer, S. J., Hendriksz, T. T. (2007) Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am. J. Kidney Dis. 49, 615–625.
<https://doi.org/10.1053/j.ajkd.2007.02.268>
